Kamada - High Quality Pharmaceuticals
    Portuguese
  Homepage   About us   Products   Capabilities   Clinical Development   Partners   Investor Relations   News & Events   Contact us  
 
Press Releases
Events
Press Kit
    Press Releases
 
2010|2009|2008|2007|2006|

Feb | Mar | Apr | May | Jun | Jul | Aug |
 
 
Kamada Passes Quality Assurance Audit by Israel's Ministry of Health; Company is preparing for Quality Audit by USFDA
June 28, 2009
...

Click here to read the full Press Release
 
 
Kamada Reports Positive Proof-of-Concept Data for Inhaled Alpha-1 Antitrypsin in Bronchiectasis
June 9, 2009

Weizmann Science Park, Ness Ziona, Israel, June 9, 2009 – Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today positive proof of concept data from a phase II, proof of concept study with its ...

Click here to read the full Press Release

 
 
Kamada Submits U.S. Biologics License Application for the First Liquid, Ready to Use AAT for the Treatment of Alpha-1 Antitrypsin Deficiency
June 2, 2009

NESS ZIONA, Israel, Kamada (TASE:KMDA) – a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that it has submitted a Biologics License Application (“BLA”) to the U.S. Food and Drug Administration (...

Click here to read the full Press Release

 
 
    More

Sign up to automatically receive e-mail alerts from Kamada
 
 
All rights reserved to Kamada © 2010 Terms and Conditions | Privacy Policy | Colours